Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma

Adaptive MR-guided radiotherapy (MRgRT) is a new treatment paradigm and its role as a non-invasive treatment option for renal cell carcinoma is evolving. The early clinical experience to date shows that real-time plan adaptation based on the daily MRI anatomy can lead to improved target coverage and...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Brian Keller, Anna M. E. Bruynzeel, Chad Tang, Anand Swaminath, Linda Kerkmeijer, William Chu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Subjects:	MR-guided radiotherapy renal cell carcinoma stereotactic body radiotherapy MR-linac image-guided radiotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.634830/full